These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29681)

  • 21. Effect of glycyrrhetinic acid on the cyclic nucleotide system of the rat stomach.
    Amer MS; McKinney GR; Akcasu A
    Biochem Pharmacol; 1974 Nov; 23(22):3085-92. PubMed ID: 4155299
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of rat testicular guanylate cyclase during development.
    Spruill WA; Steiner AL; Earp HS
    Biochim Biophys Acta; 1979 Nov; 587(4):484-94. PubMed ID: 41593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
    Onoue H; Katusic ZS
    Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian cyclic GMP concentration and guanylate cyclase activity in immature rats after treatment with pregnant mare serum gonadotrophin.
    Patwardhan VV; Lanthier A
    J Endocrinol; 1985 Oct; 107(1):77-81. PubMed ID: 2864383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of soluble guanylate cyclase activity and cellular accumulation of cyclic guanosine 3',5'-monophosphate by the carcinogen 4-nitroquinoline 1-oxide: brief communication.
    DeRubertis FR; Craven PA
    J Natl Cancer Inst; 1977 Dec; 59(6):1741-5. PubMed ID: 72827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties and regulation of guanylate cyclase and some proposed functions for cyclic GMP.
    Murad F; Arnold WP; Mittal CK; Braughler JM
    Adv Cyclic Nucleotide Res; 1979; 11():175-204. PubMed ID: 40407
    [No Abstract]   [Full Text] [Related]  

  • 28. Blockade by N-methylhydroxylamine of activation of guanylate cyclase and elevations of guanosine 3',5'-monophosphate levels in nervous tissues.
    Deguchi T; Saito M; Kono M
    Biochim Biophys Acta; 1978 Nov; 544(1):8-19. PubMed ID: 31192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A difference in effects of physiological Ca2+ concentrations on activity of guanylate cyclase preparations obtained from the taenia caecum of guinea pig and from the longitudinal muscle of rat duodenum.
    Takayanagi I; Hisayama T; Kasuya Y
    Eur J Pharmacol; 1978 Dec; 52(3-4):389-92. PubMed ID: 32054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide-dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity.
    Fernandes D; da Silva-Santos JE; Duma D; Villela CG; Barja-Fidalgo C; Assreuy J
    Mol Pharmacol; 2006 Mar; 69(3):983-90. PubMed ID: 16326931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of adenylate cyclase inhibitor (ACI) on guanylate cyclase, phosphodiesterase and other enzymes in heart.
    Lehotay DC; Levey GS; Vesely DL; Bornet EP; Ray MV; Entman ML; Schwartz A
    J Cyclic Nucleotide Res; 1977 Feb; 3(1):55-65. PubMed ID: 14979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Escherichia coli heat-stable enterotoxin effects on intestinal guanylate cyclase and fluid secretion by quinacrine.
    Greenberg RN; Guerrant RL; Chang B; Robertson DC; Murad F
    Biochem Pharmacol; 1982 Jun; 31(11):2005-9. PubMed ID: 6126194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
    Yu SM; Kuo SC
    Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of nitrergic relaxations by a selective inhibitor of the soluble guanylate cyclase.
    Cellek S; Kasakov L; Moncada S
    Br J Pharmacol; 1996 May; 118(1):137-40. PubMed ID: 8733586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian cyclic GMP concentration and guanylate cyclase and cyclic GMP phosphodiesterase activities in proestrus rat after treatment with LH.
    Patwardhan VV; Lanthier A
    Horm Metab Res; 1987 Mar; 19(3):136-7. PubMed ID: 2883102
    [No Abstract]   [Full Text] [Related]  

  • 37. Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia).
    Takemoto DJ; Kresie R; Vaughn D
    Biochem Biophys Res Commun; 1980 May; 94(1):332-9. PubMed ID: 6104489
    [No Abstract]   [Full Text] [Related]  

  • 38. Activation of guanylate cyclase and the regulatory role of cyclic 3',5'-guanosine monophosphate.
    Severina IS
    Biochem Int; 1988 Aug; 17(2):265-78. PubMed ID: 2903739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties and subcellular distribution of guanylate cyclase activity in rat renal medulla: correlation with tissue content of guanosine 3',5'-monophosphate.
    Craven PA; DeRubertis FR
    Biochemistry; 1976 Nov; 15(23):5131-7. PubMed ID: 10967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic GMP and cell death in rat cerebellar slices.
    Garthwaite G; Garthwaite J
    Neuroscience; 1988 Jul; 26(1):321-6. PubMed ID: 2901694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.